Filing Details
- Accession Number:
- 0001209191-17-015845
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-01 16:22:09
- Reporting Period:
- 2017-02-27
- Filing Date:
- 2017-03-01
- Accepted Time:
- 2017-03-01 16:22:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1323134 | J Peter Arduini | 311 C Enterprise Drive Plainsboro NJ 08536 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-02-27 | 8,018 | $42.28 | 131,555 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-02-27 | 40,000 | $13.89 | 171,555 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-27 | 40,000 | $42.28 | 131,555 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-02-27 | 40,000 | $0.00 | 40,000 | $13.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 311,588 | 2020-03-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $41.88 to $42.53.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $41.88 to $42.53.
- One-third of the stock options vested on the first anniversary of the grant date which is March 1, 2012 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the 3rd anniversary of the grant date.
- This employee's stock option was previously reported as covering 215,794 shares of common stock at an exercise price of $27.78 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.
Billionaire Hedge Funds
